Search
for

    Glossary Venlafaxine

    prescription medication for depression and anxiety, known as Effexor

    Venlafaxine, also known by the brand name Effexor, is a prescription medication primarily used to treat major depressive disorder, anxiety, and panic disorder. It belongs to a class of drugs called serotonin-norepinephrine reuptake inhibitors (SNRIs), which work by increasing the levels of serotonin and norepinephrine, neurotransmitters that help regulate mood and anxiety.

    Sort by

    Research 30 of 103

    1. Urinary Incontinence due to Overactive Detrusor Muscle: A Rare Side Effect of Venlafaxine Case Reports in Urology · 2015 · 4 citations
    2. Venlafaxine induced hair loss: a case report Düşünen Adam · 2016 · 2 citations
    3. Cerebral Ischemia Related to Isotretinoin; Venlafaxine-Induced Alopecia; Cognitive Dysfunction with Tolterodine; Retinal Artery Occlusion after Injection of Long-Acting Risperidone; Olanzapine-Induced Chylomicronemia Presenting as Pancreatitis; Metabolic Effects of the Atypical Antipsychotics – an Editorial; Another Drug-Induced Pancreatitis – This One Caused by a Tyrosine Kinase Inhibitor; Suicide Attempts Related to Antidepressant Medications Hospital pharmacy · 2007
    4. A CASE REPORT OF PARANOID DELUSION WITH VENLAFAXINE USE Journal of the American Geriatrics Society · 2003 · 8 citations
    5. Side effects of androgen deprivation therapy: monitoring and minimizing toxicity Urology · 2003 · 228 citations
    6. Fluoxetine- and Sertraline-Related Hair Loss in a Teenager: A Case Report Klinik Psikofarmakoloji Bulteni-bulletin of Clinical Psychopharmacology · 2013 · 5 citations
    7. Table of Contents The Brown University Psychopharmacology Update · 2006
    8. Obesity and the skin: Skin physiology and skin manifestations of obesity Journal of The American Academy of Dermatology · 2007 · 405 citations
    9. The Neurobiology of Sexual Function Archives of General Psychiatry · 2000 · 393 citations
    10. REPORTS: Summary of the Recommendations on Sexual Dysfunctions in Women The Journal of Sexual Medicine · 2010 · 237 citations
    11. Sex differences in the hypothalamic–pituitary–adrenal axis’ response to stress: an important role for gonadal hormones Neuropsychopharmacology · 2019 · 197 citations
    12. Hair Loss in Women The New England Journal of Medicine · 2007 · 129 citations
    13. HRT for women with premature ovarian insufficiency: a comprehensive review Human Reproduction Open · 2017 · 61 citations
    14. Adverse Cutaneous Reactions to Antidepressants American Journal of Clinical Dermatology · 2002 · 44 citations
    15. Testosterone Improves Antidepressant‐Emergent Loss of Libido in Women: Findings from a Randomized, Double‐Blind, Placebo‐Controlled Trial The Journal of Sexual Medicine · 2014 · 36 citations
    16. Scalp Dysesthesia Related to Cervical Spine Disease JAMA Dermatology · 2012 · 33 citations
    17. The placebo effect and randomized trials: analysis of conventional medicine Urologic clinics of North America · 2002 · 26 citations
    18. Psychodermatology Advances in Psychosomatic Medicine · 2015 · 25 citations
    19. Management of the psychological comorbidities of dermatological conditions: practitioners' guidelines Clinical, Cosmetic and Investigational Dermatology · 2017 · 23 citations
    20. Obsessive-compulsive disorder in dermatology Journal der Deutschen Dermatologischen Gesellschaft · 2015 · 15 citations
    21. “Osler’s phenomenon”: misdiagnosing Cushing’s syndrome Postgraduate Medical Journal · 2003 · 11 citations
    22. Dermatosis associated with menopause Journal of Mid-life Health · 2014 · 10 citations
    23. Green formulation of spironolactone loaded chitosan coated nano lipid carrier for treatment of acne vulgaris: a randomized double-blind clinical trial Advanced Pharmaceutical Bulletin · 2023 · 8 citations
    24. Adverse cutaneous effects of psychotropic medications Expert Review of Dermatology · 2013 · 6 citations
    25. Dermoscopy of an osteonevus of Nanta International Journal of Dermatology · 2013 · 6 citations
    26. Medication Repurposing: New Uses for Old Drugs Journal of Pharmacy Technology · 2011 · 6 citations
    27. Severe hair loss associated with psyc hotropic drugs in psychiatric inpatients—Data from an observational pharmacovigilance program in German-speaking countries European Psychiatry · 2018 · 5 citations
    28. Update on psychodermatological disorders Expert Review of Dermatology · 2010 · 5 citations
    29. RETIRED: Managing Menopause Chapter 8 Sexuality and Menopause Journal of obstetrics and gynaecology Canada · 2014 · 3 citations
    30. Psychotropic Treatment of Psychodermatologic Disorders Actas Dermo-Sifiliográficas · 2010 · 3 citations